Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation

Journal of Lipid Research(2025)10.1016/j.jlr.2025.100901Source: DataRank Database

Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation is a research paper published in Journal of Lipid Research (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 0.00)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Sandra Torres ORCID,Raquel Fucho ORCID,Susana Núñez,Ferràn Torres ORCID,Joana Ferrer ORCID

Live enrichment

PubMed:40967384 PMC:PMC12550793 OpenAlex:https://openalex.org/W4414225051

National Plan for Scientific and Technical Research and Innovation

Grant: PID2023-148803OB-100

Fundación Mutua Madrileña

Grant: PID2022-142956OB-100

Fundación Mutua Madrileña

Grant: PID2022-140169OB-C22

Generalitat de Catalunya

Grant: EHD25PI01

Generalitat de Catalunya

Grant: SGR-2021-00491

Generalitat de Catalunya

Grant: RYC2023-042649-I

National Cancer Institute

Grant: PO1 CA281819-01A1

European Commission

Grant: 101095679

Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

European Regional Development Fund

Agencia Estatal de Investigación

National Institutes of Health

Agència de Gestió d'Ajuts Universitaris i de Recerca

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by-nc-nd

journalhttps://www.jlr.org/article/S0022-2275(25)00163-4/pdf

publisherhttps://www.jlr.org/article/S0022-2275(25)00163-4/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022227525001634?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022227525001634?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jlr.2025.100901

Fields of Study

Organ Transplantation Techniques and OutcomesLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation0303 health sciences03 medical and health sciences

MeSH Terms

AdultCholesterolFatty LiverFemaleGraft SurvivalHumansHydroxymethylglutaryl CoA ReductasesLiverMaleMiddle AgedLiver TransplantationSterol Regulatory Element Binding Protein 2

Keywords

SteatosisLiver transplantationCholesterolFatty liverTransplantationGeneGene expressionLipid profileGraft LossSteatotic GraftsMaleAdultGraft SurvivalMiddle AgedLiverHumansFemaleHydroxymethylglutaryl CoA ReductasesPatient-oriented and Epidemiological ResearchSterol Regulatory Element Binding Protein 2